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ABSTRACT
Background: Increased cardiac apoptosis is a hallmark of the elderly, which in turn increases the risk for
developing cardiac disease. The overexpression of Omi/HtrA2 mRNA and protein contributes to apoptosis in the
aged heart. Heat shock factor 1 (HSF1) is a transcription factor that binds to the promoter of Omi/HtrA2 in the
aging myocardium. However, whether HSF1 participates in cardiomyocyte apoptosis via transcriptional regulation
of Omi/HtrA2 remains unclear. The present study was designed to investigate whether HSF1 plays a role in
Omi/HtrA2 transcriptional regulation and myocardial apoptosis.
Methods and Results: Assessment of the hearts of mice of different ages was performed, which indicated a
decrease in cardiac function reserve and an increase in mitochondrial apoptosis. Omi/HtrA2 overexpression in the
elderly was negatively correlated with left ventricular function after exercise overload and positively correlated
with myocardial Caspase-9 apoptosis. Chromatin immunoprecipitation (ChIP) of aging hearts and plasmid
transfection/RNA interference of H9C2 cells revealed that enhancement of HSF1 expression promotes Omi/HtrA2
expression by inducing the promoter activity of Omi/HtrA2 while also increasing mitochondrial apoptosis by
upregulating Omi/HtrA2 expression.
Conclusions: HSF1 acts as a transcriptional factor that induces Omi/HtrA2 expression and Caspase-9 apoptosis in
aged cardiomyocytes, while also decreasing cardiac function reserve.

INTRODUCTION
Aging is a major cardiovascular risk factor [1].
Cardiomyocyte apoptosis increases during aging, which
in turn has been shown to be related to decreased
cardiac reserve [2] and increased sensitivity to ischemia
reperfusion injury [3], stress overload, and other
cardiovascular diseases [4]. Studies have shown that
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mitochondria play an important role in regulating
apoptosis during aging [5]. However, the molecular
mechanism of mitochondrial-mediated apoptosis in the
aging heart remains unclear.
Omi/HtrA2 is a pro-apoptotic protein located in the
mitochondria, which is released into the cytoplasm after
an apoptotic stimulus [6], initiating apoptosis [7]. Our
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preliminary study found that Omi/HtrA2 is released
from the mitochondria and into the cytoplasm during
myocardial ischemia-reperfusion (I/R) injury in rats,
which in turn increases ischemia-reperfusion injury [8].

with ages above 18 months had developed hearing loss.
These findings supported that the mice used in this
study were adequately grouped to simulate the process
of physiological aging.

Our preliminary study found increased Omi/HtrA2
mRNA and protein expression in the myocardium of
aging rats, aggravating I/R injury by inducing the
apoptosis of myocardial cell [9]. Cardiac-specific
overexpression of mitochondrial Omi/HtrA2 promotes
cardiomyocyte apoptosis and heart dysfunction [10],
activates Caspases, and disrupts mitochondrial
homeostasis in the aged heart [11]. However, the
regulatory mechanism of Omi/HtrA2 in aged myocardial
tissues remains elusive.

To determine whether cardiac reserve had changed in
aging mice, echocardiography was performed at different
ages (4 months, 12 months, 18 months, and 24 months
old). In our study, ejection fraction (EF) and fractional
shortening (FS) reflected cardiac systolic function, and
E/A ratio was tested for diastolic function. No significant
differences were observed in EF, left ventricular FS, and
E/A ratio at rest. However, after exercise load, the EF
(Figure 1A and 1B), FS (Figure 1A and 1C) of the 24month-old groups decreased compared to the 4-monthold group, and the E/A ratio (Figure 1A and 1D) of the
18- and 24-month-old groups decreased compared to the
4-month-old group, suggesting a decrease in the cardiac
reserve of the aged group. Simultaneously, the results of
echocardiography showed that the left ventricular enddiastolic diameter (LVID(d)) increased (Figure 1E), the
left ventricular posterior wall end-diastolic thickness
(LVPW(d)) increased (Figure 1F), and the mass of the
left ventricle (LV mass) increased (Figure 1G) with
aging. These findings were suggestive of left ventricular
hypertrophy. We also measured the ratio of the heart
weight to total weight to observe changes in the aging
heart, which showed that the ratio decreased with age
(Figure 1H). We measured the systolic blood pressure to
evaluate changes in vascular function and found that the
systolic blood pressure of the mice did not significantly
change with age (Supplementary Figure 2). We also
evaluated the levels of atherogenic process in aorta, there
were no distinctly different pathological changes in aorta
of aged rats by HE staining, Masson trichrome stain and
sirus red stain (Supplementary Figure 3A–3C), however.
To evaluate thoracic aorta endarterium morphology,
thoracic aorta endothelium biomarkers CD31 was
detected by immunohistochemical stain (IHC). It showed
that the damage of intimal layer continuity, loss of some
vascular endothelial cells, shallow staining, and enlarged
junction space in aging (Supplementary Figure 3D). It
dedicated that the endothelium injury in aged aorta.

Further investigation of the mechanism of increased
Omi/HtrA2 using a luciferase reporter assay indicated
that the Omi/HtrA2 promoter core regions are situated
within -1,205 to -838 bp and -146 to +93 bp.
Furthermore, we confirmed that Heat shock factor 1
(HSF1) can bind to the Omi/HtrA2 promoter in the
myocardium as a transcription factor [12]. These
findings suggest that HSF1 is an important
transcriptional factor that is involved in regulating
Omi/HtrA2 mRNA levels. However, the role and
expression of HSF1 and whether it regulates
Omi/HtrA2 in the aging heart remain elusive.
In this study, we evaluated cardiac reserve and cardiac
myocyte apoptosis in the aging mouse. We report that
the overexpressing of the transcription factor HSF1 in
cardiomyocytes up-regulates Omi/HtrA2 expression and
contributes to mitochondrial apoptosis in aged cardiac
myocytes. Our study investigated the regulatory
mechanism of Omi/HtrA2 expression by HSF1 in the
aging heart, and it provides a novel theory of HSF1 in
myocardial apoptosis.

RESULTS
Cardiac reserve decreases in aged mice
The mouse aging model was constructed using four
groups of mice based on ages: 4 months (young group),
12 months (middle age group), 18 months (presenium
group), and 24 months (aging group) [13] and evaluated
using different classic aging indexes: the mRNA and
protein levels of aging-associated proteins p16, p53, and
β-galactosidase The results showed that the mRNA
levels of p16 and p53 increased with age (see
Supplementary Figure 1A and 1B),. The protein levels
of p16, p53, and β-galactosidase also increased with age
(see Supplementary Figure 1C–1F). Mice 18 months
and older showed poor in illustriousness and mobility,
particularly those of age 24 months. Most of the mice
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The rate of apoptosis of cardiomyocytes increases in
aged mice via the mitochondrial apoptotic pathway
and is negatively correlated to cardiac systolic
function
Reduction of antioxidation ability and increasing
oxidative stress occurred in aged heart. Levels of
antioxidants showed that total antioxidant activity (TAOC) decreased (Supplementary Figure 4A), SOD
activity decreased with age (see Supplementary Figure
4B), and malondialdehyde (MDA) increased
(Supplementary Figure 4C) in aged myocytes. The
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production of ROS in general and mitochondrial in
particular was increased (Supplementary Figure 4D, 4E)
in aging heart compared with 4 month old mice. The
level of ATP in aging myocardium was decreased
(Supplementary Figure 4F).
To evaluate the relevance of cardiomyocyte apoptosis
and decreased cardiac reserve in aged mice,
cardiomyocyte apoptosis in mice from different age
groups was assessed by TUNEL staining myocardial
tissue sections and determination of Caspase activity.
The results demonstrated that the number TUNELpositive cells increased with age (Figure 2A). In
addition, Caspase-3 activity (a critical effector Caspase)

in mouse cardiomyocytes also increased with age
(Figure 2B). Caspase-9 activity (an initiator Caspase in
the mitochondrial pathway) significantly increased in
the older groups (18 and 24 months) (Figure 2C).
However, Caspase-8 activity (an initiator Caspase of the
extrinsic pathway) (Figure 2D) and Caspase-12 activity
(an endoplasmic reticulum-specific stress-activated
Caspase pathway) (Figure 2E) did not change. These
results indicated that mitochondrial apoptosis is the
main pathway in the aged heart. Caspase-9 activity was
negatively correlated with left cardiac systolic function
(EF, FS) after exercise (Figure 2F and 2G). However,
there was also no correlation between Caspase-9 and
diastolic function (Supplementary Figure 5).

Figure 1. The cardiac reserve function decreases in aging mice. Echocardiography of the mice (A). Eject factor (EF, %) (B). Fractional

shortening (FS, %) (C). The ratio of the early to late ventricular filling velocities (E/A ratio) (D). Left ventricular end-diastolic diameter (LVID(d),
mm) (E). Left ventricular posterior wall end-diastolic thickness (LVPW(d), mm) (F). Left ventricular mass (LV mass, mg) (G). The ratio of the
heart weight to total weight (H). Data are represented as mean +/- SEM. n = 6 per group. *P<0.05, **P<0.01 vs. 4 m. m=month.
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The upregulation of Omi/HtrA2 in aging
myocardium is negatively correlated with the decline
in left ventricular function and the ratio of heart
weight to total weight
To determine the expression of Omi/HtrA2 (a proapoptotic protein) in the aging heart, we detected its
mRNA and protein levels by RT-qPCR and western blot
analyses. The results showed that the mRNA and protein
levels of Omi/HtrA2 significantly increased in the
presenium group (18 months) and the older group (24
months) compared to the young group (Figure 3A and
3B). To evaluate the mRNA levels of Omi/HtrA2 and

cardiac function in aging mice, we analyzed the
correlation in the mRNA levels of Omi/HtrA2 as well as
in the EF, FS, and diastolic index. The results showed that
the mRNA levels of Omi/HtrA2 were negatively
correlated with left ventricular systolic function (Figure
3C and 3D), but had no significant correlation with
diastolic function (Figure 3E). We also analyzed
Omi/HtrA2 mRNA, LVID(d), LVPW(d), and LV mass to
explore the correlation between Omi/HtrA2 mRNA level
and cardiac structure in aging mice, in which we found no
significant correlation (Figure 3F–3H). However, the
mRNA level of Omi/HtrA2 was negatively correlated
with the ratio of heart weight to total weight (Figure 3I).

Figure 2. Aging mice exhibit higher cardiomyocytes apoptotic rates and Caspase-9 activity but lower cardiac systolic
function. TUNEL labeling and apoptotic index of paraffin-embedded cardiac tissues (A). Evaluation of Caspase-3, Caspase-9, Caspase-8,

Caspase-12 activity in mice of different ages (B–E), data are represented as mean +/- SEM. n = 6 per group. *P<0.05, **P<0.01 vs. 4m.
m=month. The correlation analysis between the expression of Caspase- 9 activity and ejection fraction (EF, %) (F). The correlation analysis
between the Caspase -9 activity and fractional shortening (FS, %) (G). n=32.
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Overexpression of HSF1 in myocardium promotes
Omi/HtrA2 mRNA and protein expression by
enhancing the promoter activity of Omi/HtrA2
HSF1 is a critical transcriptional factor correlated with
chronic stresses and heart disease [14]. To investigate
changes in HSF1 in the aging heart, HSF1 expression
was detected by western blot analysis of heart tissues.
High levels of the HSF1 protein were detected in the
aged cardiac myocytes (Figure 4A). In our previous
study, we found that HSF1 binds to the Omi/HtrA2

promoter as a transcription factor. To determine whether
increased HSF1 is involved in Omi/HtrA2 expression, we
detected the nucleoprotein in cardiomyocytes and also
assessed changes in the binding ability of HSF1 to the
promoter by ChIP. An increase in HSF1 levels in the
nucleus was observed (Figure 4B), as well as binding to
the Omi/HtrA2 promoter were observed in the aged heart
(Figure 4C). To gain a deeper understanding of the
mechanism involved in HSF1-based regulation of
Omi/HtrA2, HSF1-overexpressing NIH3T3 cells were
prepared by transiently transfecting pcDNA3.1-HSF1

Figure 3. Correlation analysis of Omi/HtrA2 mRNA expression and cardiac reserve function with aging. The mRNA levels of
Omi/HtrA2 were assessed by quantitative RT-PCR (A). Protein expression was evaluated by western blotting (B). Data are represented as
mean +/- SEM, n = 6 per group. *P<0.05, **P<0.01 vs. 4m. m=month. A strong negative correlation between Omi/HtrA2 mRNA expression
and ejection fraction (EF, %) was observed with aging (C). A significant linear negative correlation between Omi/HtrA2 mRNA expression and
fractional shortening (FS, %) with aging (D). No significant linear correlation between Omi/HtrA2mRNA expression and E/A ratio (E). No
significant linear correlation between Omi/HtrA2 mRNA levels and left ventricular end-systolic diameter (LVID, mm) was observed (F). The
correlation analysis between Omi/HtrA2 mRNA levels and left ventricular posterior wall end-systolic thickness (LVPW, mm) (G). Correlation
analysis between Omi/HtrA2 mRNA levels and left ventricular mass (LV mass, mg) (H). A significant linear negative correlation between
Omi/HtrA2 mRNA expression and heart/body weight with aging (I).

www.aging-us.com

8986

AGING

(Figure 4D). HSF1 protein in the nucleus was regulated
in the transfected NIH3T3 cells (Figure 4E).
Overexpression of HSF1 increased the mRNA and
protein levels of Omi/HtrA2 (Figure 4F and 4G), and the
activity of the Omi/HtrA2 promoter was enhanced
(Figure 4H).
To further confirm that HSF1 regulates Omi/HtrA2
expression through transcription activation, we detected

the activity of the Omi/HtrA2 promoter after RNA
interference of HSF1. The introduction of small
interfering RNA (siRNA) resulted in the inhibition of
HSF1 expression in the NIH3T3 cells (Figure 4I). The
HSF1 nucleoprotein was downregulated (Figure 4J).
Knocking down HSF1 resulted in a reduction in the
activity of the Omi/HtrA2 promoter (Figure 4K), as
well as the mRNA (Figure 4L) and protein levels of
Omi/HtrA2 (Figure 4M).

Figure 4. Overexpression of HSF1 in the myocardium promotes the expression of Omi mRNA and protein levels by enhancing
the activity of the promoter of Omi/HtrA2. Total and nucleoprotein HSF1 expression was increased in aging myocardium, GAPDH, and

histone H3 as internal control (A, B). Data are represented as mean +/- SEM. **P< 0.01 vs. young, n = 6 per group. The binding of HSF1 to the
Omi/HtrA2 promoter increased in aging mice (C). Total and nucleoprotein HSF1 expression increased after transient transfection of
pcDNA3.1-HSF1 (D, E). mRNA and protein levels of Omi/HtrA2 increased after transient transfection of pcDNA3.1-HSF1 (F, G). Relative
luciferase activity of PGL-239 increased after transient transfection of pcDNA3.1-HSF1 (H). Values are means ± SEM, *P<0.05, **P<0.01 vs.
pcDNA3.1, n = 3. Total and nucleoprotein HSF1 expression decreased after transient transfection of siRNA-HSF1 (I, J). Relative luciferase
activity of PGL-239 decreased after transient transfection of siRNA -HSF1 (K). mRNA and protein levels of Omi/HtrA2 increased after transient
transfection of pcDNA3.1-HSF1 (L, M), Values are means ± SEM, #P<0.05, ##P<0.01 vs. scramble, n = 3.
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Overexpression of HSF1 induces mitochondria
apoptosis by regulating Omi/HtrA2 expression in
H9C2 cells
To determine the effects of HSF1 on Omi/HtrA2mediated apoptosis in cardiomyocyte, we upregulated
HSF1 by transiently transfecting the pcDNA3.1-HSF1
plasmid into cultured H9C2 cells, and HSF1 had no
change after knockdown Omi/HtrA2 by RNA
interference compared to that in the HSF1+scramble
group (Figure 5A and 5B). Omi/HtrA2 expression

increased in the pcDNA3.1-HSF1 group. Then,
Omi/HtrA2 expression was silenced by RNA interference
compared to that in the HSF1+scramble group (Figure
5A and 5C).
We demonstrated that Caspase-9 activity increased in the
pcDNA3.1-HSF1 group, and the effect was suppressed
by siRNA Omi/HtrA2 (Figure 5D). In addition, Caspase3 activity was retained in the pcDNA3.1-HSF1 group,
and similar change was observed after transfecting
siRNA Omi/HtrA2 (Figure 5E).

Figure 5. Overexpression of HSF1 participates in mitochondrial apoptosis by regulating Omi/HtrA2 expression in H9C2 cells.

HSF1 expression increased after transfection of plasmid pcDNA3.1, which was not affected by RNAi Omi/HtrA2 (A, B). Omi/HtrA2 protein
expression increased after transfection of plasmid pcDNA3.1, which decreased after RNAi Omi/HtrA2 (A, C). Caspase -9 activity was induced
by HSF1 overexpression, which was reversed after transient transfection of si-Omi/HtrA2 (D). Caspase-3 activity was suppressed by HSF1
overexpression, but similar change was detected after RNAi using Omi/HtrA2 (E). Data are represented as mean +/- SEM. *P<0.05, **P<0.01
vs. pcDNA3.1, #P<0.05, ##P<0.01 vs. HSF1+scramble, n = 4.
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DISCUSSION
The present study describes the novel roles of HSF1 in
regulating the pro-apoptosis protein Omi/HtrA2 in aged
cardiomyocytes, which include the following: (i) using
cardiac tissue, we demonstrated that HSF1 protein as
well as its level in the nucleus were increased in the
aged heart; (ii) overexpression of HSF1 induces
Omi/HtrA2 expression by enhancing the promoter
activity of Omi/HtrA2 in aged cardiomyocytes; (iii)
overexpression of HSF1 enhances mitochondria apoptosis
by upregulating Omi/HtrA2 in vivo. Taken together, these
results indicate that HSF1 as a transcriptional factor
participates in myocardial mitochondria apoptosis by
enhancing the promoter activity of the pro-apoptosis gene
Omi/HtrA2 in aged cardiomyocytes.
Aging is a vital risk factor that increases the risk of
developing cardiovascular decrease. A decrease in cardiac
reserve [15], high sensitivity to ischemia reperfusion injury
[16], and stress load [17], are characteristics of the elderly
that reduce the quality of life. Cardiomyocyte apoptosis
increases the risk of cardiovascular disease in the aged
heart [13]. In this study, four groups of mice of different
ages were used to simulate the process of physiological
aging. We demonstrated that cardiac functional reserve
decreased in the aged group after exercise, whereas no
significant change was observed at the resting state. Aorta
endothelium damaged in aged mice. Oxidant/antioxidant
imbalance was more pronounced, In particular,
mitochondrial oxidative stress increased. Apoptosis
increased mainly via the mitochondrial pathway and was
correlated to cardiac functional reserve, particularly the left
heart diastolic function. These findings indicate that
mitochondrial pathway apoptosis contributes to deficient
cardiac functional reserve.
Several studies have indicated that the mitochondriadependent apoptosis signaling pathway is more active in
multiple organs of the elderly, for instance, muscle [18],
heart [19]. Our previous study showed that the
increased expression of Omi (also known as HtrA2)
enhances MI/R injury in aged hearts [9] by inducing
myocardial mitochondrial apoptosis [11].
Omi/HtrA2 is a serine protease located in the eukaryotic
mitochondria, belonging to the high temperature
requirement (HtrA) family. Studies have shown that mice
with the motor neuron degeneration 2 (mnd2) mutation
[20] and mice with Omi/HtrA2 knockout [21] exhibit a
premature phenotype, which include osteoporosis,
muscle atrophy, cardiac enlargement, and shortened life
expectancy. Kang et al. reported that Omi/HtrA2 can
regulate the protein quality of the mitochondrial
intermembrane space [22], which is important for
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maintaining mitochondrial homeostasis. Disruption of
mitochondrial homeostasis may be the reason for
neurodegenerative disorders and premature senescence in
non-nerve tissues [23].
In this study, we found that Omi/HtrA2 mRNA and
protein levels increased in the presenium, with an even
greater increase in the elderly group compared to the
young group. The results were consistent with that of
Caspase-9 activity. We also observed that the mRNA
level of Omi/HtrA2 was negatively correlated with left
ventricular systolic function after exercise and the ratio of
heart weight to total weight. This study supported our
previous findings that Omi/HtrA2 mRNA and protein
levels increased with age and suggest that alterations in
Omi/HtrA2 transcription and protein levels are closely
associated with cardiac reserve by inducing
mitochondrial pathway apoptosis. However, the
regulatory mechanism of Omi/HtrA2 transcription in the
aged heart remains elusive.
Many factors impact on the expression of Omi/HtrA2.
Prior study showed that hypoxia-inducible factor (HIF)1alpha inhibits Omi/HtrA2 expression and suppresses
hepatocellular carcinoma cell apoptosis [7]. We
previously confirmed that HSF1 can bind to the
promoter region of Omi/HtrA2 in the myocardium by
ChIP assay. This study confirmed that HSF1 as a
transcription factor can regulate Omi/HtrA2 expression
by showing that the nucleoprotein expression of HSF1
in the aging myocardium increased, along with the
binding to the Omi/HtrA2 promoter. We also confirmed
that overexpressed HSF1 can increase Omi/HtrA2
mRNA and protein levels by enhancing the activity of
the Omi/HtrA2 promoter. These findings suggest that
the activation of Omi/HtrA2 by HSF1 may be one of the
mechanisms of Omi/HtrA2 overexpression in the aged
myocardium.
HSF1 is a major factor in regulating the expression of
heat shock proteins, plays an important role in
maintaining the accurate folding of proteins [14] and
cellular homeostasis [24], and participates in cellular
processes such as the stress response, aging, and
carcinogenesis [14]. HSF1 performs very important
functions in cardiovascular disease. HSF1 protects
cardiomyocyte from I/R injury [25] and HSF1
phosphorylation, which is activated by angiotensin II
(ANG II), resulting in cardiac hypertrophy [26].
Furthermore, ANG II promotes insulin-like growth factor
II receptor (IGF-IIR) expression and cardiomyocyte
apoptosis by inhibiting HSF1 via c-Jun N-terminal kinase
(JNK) activation and sirtuin 1 (SIRT1) degradation [27].
HSF1 expression increases in muscle tissue during aging
[28]; however, HSF1-controlled chaperone capacity is
suppressed in aged muscle cells [29]. This suggests that
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HSF1 has a negative effect during aging. We have shown
that HSF1 as a transcription factor of Omi/HtrA2
enhances pro-apoptotic Omi/HtrA2 expression, thereby
inducing cardiomyocyte apoptosis. HSF1 inhibits
cardiomyocyte apoptosis but enhances mitochondrial
apoptosis by upregulating Omi/HtrA2 expression.
In
summary,
HSF1
enhances
cardiomyocyte
mitochondria -mediated apoptosis by activating
Omi/HtrA2 transcription, and Omi/HtrA2 expression
influences the cardiac function reserve of the aging heart.

MATERIALS AND METHODS
Animals
The C57BL/6 male mice at various ages, namely, 4
months (young group), 12 months (middle age group),
18 months (presenium group), and 24 months (aging
group) were purchased from Suzhou Ai Er Mai Te
Technology Co., Ltd. (Suzhou, China). All animal
experiments were conducted according to the Guide for
the Use and Care of Animals of the National Institutes of
Health (NIH Publication No. 85-23, revised 1996). All
animals had free access to standard laboratory rat chow
and tap water. Until parturition, rats were housed
individually in a room at constant temperature (24 °C)
and under a 12-h light–dark cycle.
Cell lines, cell culture, and transfection
The NIH3T3 cell line was purchased from the Basic
Medical Cell Center of Peking Union Medical College
(Beijing, China). The NIH3T3 cells were grown in
Dulbecco’s modified Eagle’s medium (high glucose)
with 10% calf serum. The cells were cultured at 37°C
and 5% CO2. Transfection was performed using
Lipofectamine 3000 reagent (Invitrogen, USA) according
to the manufacturer’s instructions. Cells were inoculated
in six-well plates and divided into two groups: pcDNA3.1 (no insert) and pcDNA3.1-HSF1. The medium was
aspirated and replaced with serum-free medium without
antibiotics 4h before transfection. Lipofectamine 3000
(3.75 μL) was diluted with 125 μL Opti-MEM and 2.5 μg
plasmid, 5 μL p3000 were diluted with 125 μL OptiMEM® reduced-serum medium (Gibco, Carlsbad, CA,
USA). The mixtures were incubated for 20 min at room
temperature and then added to the cells with antibioticfree complete medium. Cell lysates were harvested 72h
after transfection.

inoculated in six-well plates and divided into two
groups: scramble/HSF1+scramble; si-Omi/HSF1+siOmi. HSF1-siRNA5'-GGACACAACCGGAGCCCAA3' (25pmol), and RNAiMAX were diluted with OptiMEM (#31985; Gibco, Carlsbad, CA, USA). The
mixtures were incubated for 20 min and then added to
the cells. The medium was aspirated and replaced with
Dulbecco’s modified Eagle’s medium (high glucose)
supplemented with 10% calf serum. The cells were
harvested 72 h after transfection.
Western blot analysis
Myocardium tissues were harvested for Western Blot
following standard protocol. Nucleoprotein was extracted
according to the Nuclear and Cytoplasmic Protein
Extraction Kit (P0027, Beyotime Institute of
Biotechnology, Suzhou, China). 50 μg/lane protein or 20
μg/lane nucleoprotein Proteins were run on 10% SDSPAGE, and then electrotransferred onto polyvinylidene
difluoride membranes. The membranes were incubated
with the primary antibodies anti-HSF1(#4356; 1:1000;
Cell Signaling Technology, Danvers, MA, USA), antiOmi/HtrA2(#2176; 1:1000; Cell Signaling Technology,
Danvers, MA, USA), anti-GAPDH(#2118; 1:1000; Cell
Signaling Technology, Danvers, MA, USA), or antiHistone H3 (#4499; 1:1000; Cell Signaling Technology,
Danvers, MA, USA) overnight at 4°C. After incubation
with the corresponding secondary antibodies, the
membrane was developed with a chemiluminescent
substrate (Bio-Rad), and protein bands were measured
using the ImageJ software.
Quantitative PCR
The total RNA of was isolated using TRIzol™ reagent
(Invitrogen; USA) according to the manufacturer’s
instructions. Total RNA was reverse-transcribed using a
PrimeScript™ RT Master Mix (#RR036A; Takara),
gene expression was assessed by real-time PCR using a
SYBR PrimeScript™ RT-PCR kit (#RR820A; Takara)
as previously described [12]. Primers for QRT-PCR
(SYBR) were designed and synthesized as follows:
Omi-F: 5′-ATCTCCTTTGCCATCCCTTC-3′; Omi-R:
5′-GGTCAGCATCATCACTCCAA-3′; p16-F: 5′-CGT
GTCTAGCATGTGGCTTT-3′; P16-R: 5′-GCCTTCGC
TCAGTTTCTCAT-3′; p53-F: 5′-CGTAAACGCTTCG
AGATGTTC-3′; P53-R: 5′-GCCCTTCTTGGTCTTCA
GGT-3′; HSF1-F: 5′-GGCAGTACCTTGGATCAGGA3′; HSF1-R: 5′-CAAGTGTGGCTGTGAAGCTG -3′;.

siRNA oligos and transfection

Luciferase activity assay

Transfection of NIH3T3 cells was performed using
Lipofectamine RNAiMAX (Thermo Scientific, USA)
according to the manufacturer’s instructions. Cells were

Luciferase activity assay was performed as previously
described [12]. The NIH3T3 cells were inoculated in
96-well plates and then transfected as described in the
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above methods section using Lipofectamine 3000
reagent (Invitrogen, USA). The cell lysates were
harvested 48h after transfection. The Dual-Glo®
Luciferase Assay System (#E2920; Promega, Madison,
WI, USA) was used to test the firefly luciferase and
Renilla luciferase activity using a GloMax® 96-well
microplate luminometer (Promega, Madison, WI,
USA) for measurements. Relative luciferase activity
(RLA) was the ratio of firefly luciferase to Renilla
luciferase.
Echocardiographic and hemodynamic
measurements
Left ventricular end-diastolic diameter (LVID(d)), Left
ventricular posterior wall end-diastolic thickness
(LVPW(d)), and Left atrioventricular mass (LV mass)
were measured and recorded on the left heart long axis
section (Vevo 2100, Visual Sonic, Canada). Eject factor
(EF) and Fractional shortening (FS) were obtained by
M-type ultrasound, and all data were measured three
times and averaged. E-peak and late-filling A were
evaluated using a mitral valve flow chart. The E/A ratio
was calculated to reflect left ventricular diastolic
function. LVID(d), LVPW(d) and LV mass were
measured without any treatment or exercise load (using
animal experiment treadmill at a runway speed of 15
m/min and exercise time of 10 min), and EF, FS, and
E/A ratio were recorded.
Detection of mouse blood pressure
We used the mouse tail arterial pulse pressure method
to measure blood pressure; the sensor was set at the
tail of the mouse, and blood pressure was determined
by monitoring the blood flow signal while inflating
and deflating the tail artery and releasing the
pressure.
Terminal-deoxynucleotidyl transferase mediated
nick end labeling (TUNEL) staining of mouse hearts
and determination of Caspase protease activity
The myocardial tissues were perfused with 4%
paraformaldehyde in PBS, and then embedded in
paraffin. TUNEL staining (In Situ Cell Death Detection
Kit, Roche) was performed according to the
manufacturer's instructions. The percentage of apoptotic
nuclei in each slide was used to determine the apoptotic
index. The concentration of the proteins extracted from
myocardial tissue was determined using the Bradford
assay. Caspase protease activity was determined with a
colorimetric assay kit according to the manufacturer’s
instructions. Briefly, a mixture consisting of 50 μL of the
2×assay buffer, 30 μL of the sample supernatant, and 10
μL of ddH2O was prepared. Then, the Ac-DEVD-
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AFC/Ac-IETD-AFC/AC-IEHD-AFC/AC-ATAD-AFC
substrate (10μL) was added to each well of a 96-well
microplate. The absorbance of each well was then
measured on a fluorescent microplate reader (Excitation:
400 nm and Emission: 508 nm).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay (Magna ChIP G Tissue Kit #17-20000;
Millipore EZ-ChIP, Darmstadt, Germany) was conducted
as previously reported [12], according to the
manufacturer's instructions. Mouse myocardial tissues
was crosslinked with 1% formaldehyde, then sonicated to
shear chromatin DNA to sizes within the range of 200500 bp. The DNA fragments were immunoprecipitated
with rabbit α-mouse IgG as control and also with
antibodies specific to HSF1 (#4356; Cell Signaling
Technology, Danvers, MA, USA). Immunoprecipitation
was performed overnight at 4°C. The protein/DNA
complexes and reverse crosslinks of protein/DNA
complexes to free DNA were eluted, and the
immunoprecipitated chromatin was amplified using
primers corresponding to the Omi/HtrA2 promoter.
Primers were as follows: Omi promoter-F: 5′GCTACCGTCGTGCCCTGCTT-3′; Omi promoter-R:
5′-ATGCCCGAAGGCTCCAGTTT-3′
Immunohistochemical stain (IHC)
After being embedded in paraffin, all samples of
thoracic aorta tissue cubes were sectioned into three 4mm-thick slices and stained with hematoxylin and eosin
(HE), Masson’s trichrome and Sirius red stain.
Thoracic aorta tissue samples (1cm3) were fixed with
para-formaldehyde and embedded in paraffin. 4 μm
sections were incubated in a dilution of rabbit antiCD31 antibody (ab182981,1:2000, Abcam, USA)
overnight at 4°C. Immuno-reactivity was detected by
goat anti-rabbit IgG (zsgb, CHN). After dehydration, all
sections were observed and photographed using a Nikon
microscope fitted with a camera (NIKON Corporation,
JPN).
Antioxidant activity assay and Free radicals
Total antioxidant capacity (T-AOC) (ABTS method),
SOD activity (WST-1 method) and malondialdehyde
(MDA) (TBA method were detected according to the
manufacturer’s instructions by corresponding kits
(A015-2-1, A001-3, A003-1-2, Nanjing Jiancheng
Bioengineering Institute, Nanjing, China). The
absorbance was measured using a microplate reader at
corresponding wavelength. The T-AOC, SOD activity
and MDA were calculated with provided formulas
separately.

AGING

Assessment of reactive oxygen species (ROS)
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SUPPLEMENTARY MATERIALS
Supplementary Figures

Supplementary Figure 1. Identification of the aging mice. mRNA expression of p16 (A) and p53 (B) were increased, protein expression
of p16, p53 and β-gal (C–F) were increased with aging. Data are represented as mean +/- SEM. n = 6 per group. * p < 0.05 , ** p < 0.01 vs. 4m.
m=month.
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Supplementary Figure 2. Systolic blood pressure of the mice. Compared with 4m group, Systolic blood pressure had no significant
changed with aging. Data are represented as mean +/- SEM. n = 6 per group. m=month.

Supplementary Figure 3. Thoracic aorta endothelium damaged in aged mice. (A) HE staining of thoracic aorta; (B) Masson
trichrome stain of thoracic aorta; (C) Sirius red stain of thoracic aorta; (D) immunohistochemistry staining of endothelium marker CD31 of
thoracic aorta. m=month. n = 6 per group. bar=20μm.
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Supplementary Figure 4. Antioxidation ability decreased and oxidative stress increased in aged heart. Total antioxidant activity

(T-AOC) decreased (A), SOD activity decreased with age (B), and malondialdehyde (MDA) increased (C) in aged myocytes. The production of
ROS in general (D) and mitochondrial in particular (E) was increased in aging heart, ATP was decreased in aging myocardium (F), compared
with 4 month old mice. Data are represented as mean +/- SEM. n = 6 per group. * p < 0.05 , ** p < 0.01, *** p < 0.001 vs. 4m. m=month.

Supplementary Figure 5. No correlation between caspase-9 activity and diastolic function. n=32.
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